Transcriptomic analysis of the microdissected tumors (GSE164665, Fig. 4a) revealed higher expression of CXCR2, a known receptor for CXCL8, in stromal cells, whereas SLC6A14 was predominantly expressed in cancer cells (Fig. 4a). This evidence concerns the gene CXCL8 and cancer.